A recombinant adenoviral vector with a specific tropism to CD4-positive cells: a new tool for HIV-1 inhibition.
Abtin BehmardiTouraj FarazmandfarPublished in: Drug delivery and translational research (2022)
Gene therapy can be an option to overcome the side effects of chemotherapy and prevent the development of drug-resistant HIV viruses in HIV-infected patients. The need to develop a safe and efficient vector for gene transfer is always necessary and an appropriate option might be adenovirus (Ad). The use of Ad vectors in gene delivery applications is limited due to the semi-specific tropism. A strategy to overcome this tropism limitation may be the modification of the fiber protein domain involved in the viral binding to cells. Therefore, we designed an Ad5 vector with a specific tropism to CD4 + cells containing an expression system limited to HIV-infected cells. We replaced the knob region of Ad5 fiber protein with the extracellular region of the HIV-1 envelope. We also used a specific Tat-inducible promoter to express two anti-HIV-1 shRNAs. Tropism of recombinant Ad5 was assayed by a comparison of the shRNA expression level in CEM and PBMC cells (as CD4 + cells) and HEK293 cells (as CD4 cells). HIV-1 inhibition was assayed by the determination of p24 antigen in the HIV-infected CEM cells transduced with the recombinant Ad5 vector. Our results showed that the shRNA expression was significantly higher in CEM and PBMC cells than HEK293 cells when transduced with recombinant Ad5 vector. This new Ad5 vector also inhibited HIV-1 proliferation in a Tat-inducible manner. Our new recombinant Ad5 vector has a specific tropism to CD4-positive cells that can effectively suppress the HIV-1 replication.
Keyphrases
- induced apoptosis
- hiv infected
- antiretroviral therapy
- cell cycle arrest
- drug resistant
- human immunodeficiency virus
- hepatitis c virus
- hiv positive
- oxidative stress
- hiv infected patients
- endoplasmic reticulum stress
- signaling pathway
- cell death
- dna methylation
- squamous cell carcinoma
- sars cov
- multidrug resistant
- gene expression
- mass spectrometry
- radiation therapy
- transcription factor
- gene therapy
- locally advanced
- solid phase extraction
- molecularly imprinted